Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Fibrinogen alpha Chain (FGA) Peptide

FGA Reactivité: Humain Hôte: Synthetic BP, WB, IHC
N° du produit ABIN976820
  • Antigène Tous les produits FGA
    FGA (Fibrinogen alpha Chain (FGA))
    Origine
    Humain
    Source
    • 7
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-FGA antibody (Catalog #: ARP41758_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    FGA (Fibrinogen alpha Chain (FGA))
    Synonymes
    Fib2 Peptide, ENSMUSG00000059807 Peptide, Fib Peptide, Ac1873 Peptide, Fba5e Peptide, fibrinogen alpha chain Peptide, FGA Peptide, Fga Peptide, LOC698244 Peptide
    Sujet
    FGA is the alpha component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in its gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis.The protein encoded by this gene is the alpha component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in two isoforms which vary in the carboxy-terminus.

    Alias Symbols: Fib2

    Protein Interaction Partner: BAT2,CDH5,F13A1,F2,FGA,FGB,FGG,HRG,ITGA2B,ITGB3,NID1,PLAT,SERPINA5,SERPINF2,THBS1,BAT2,CDH5,F13A1,F2,FGA,FGB,FGG,HRG,KHDRBS2,NID1,PLAT,THBS1

    Protein Size: 644
    Poids moléculaire
    71 kDa
    ID gène
    2243
    NCBI Accession
    NM_021871, NP_068657
    UniProt
    Q4QQH7
Vous êtes ici:
Support technique